NeuroCure™ Glioblastoma Targeted Therapy System / NeuroCure™

Price：￥

A 3D animation showing the targeted delivery of therapeutics across the blood-brain barrier to a tumor site.

Description :

NeuroCure™ represents a paradigm shift in treating Glioblastoma (GBM). It combines a novel small molecule drug candidate (GE-301) with a proprietary catheter-based convection-enhanced delivery (CED) system. This allows for the precise, localized administration of high-dose therapeutics directly to the tumor bed, bypassing the blood-brain barrier and minimizing systemic side effects.

Key Features :

·  Proprietary CED Catheter for precise, controlled drug infusion.

· Novel Drug Formulation (GE-301) with orphan drug designation in the US and EU.

· Real-Time Pressure Monitoring to ensure safe delivery and optimize distribution.

Online inquiry